Ocugen is currently advancing OCU400 through Phase 3 clinical development with a target Biologics License Application filing of mid-2026.

Representativeness Of Pivotal Clinical Trials Disease burden information was available for 225 (232 drug-indication combinations) of the 290 drugs (appendix exhibit A3). 11 These 225 drugs ...

Introduction Building capacity to improve sex/gender knowledge and strengthen patient engagement in clinical trials requires training and support ... educational national public forums, fact ...

Kyoto University Hospital has succeeded in transplanting pancreatic cell sheets made from induced pluripotent stem (iPS) cells into a diabetic patient ... hospital's clinical trial for treating ...

Patient recruitment for the phase 1 trial will begin soon (NCT06913608). The phase 1 clinical trial will evaluate the safety and efficacy of CLBR001 + SWI019 in patients with myositis, systemic ...

Objectives (a) To adapt the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT)-patient-reported outcome ... considerations for the participant information sheet and consent ...

On March 18, 2025, Dogwood Therapeutics, Inc. (NASDAQ:DWTX) announced that the first patient was dosed in the Phase 2b HALT-CINP (Halneuron Treatment of Chemotherapy-Induced Neuropathic Pain).

LONDON, GB / ACCESS Newswire / March 17, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce the recruitment of the second patient for its clinical trial of HG-CT-1, its proprietary ...

4 Department of Medical Oncology, San Raffaele Scientific Institute, Milan, Italy 5 Clinical Trials Office, San Raffaele Scientific Institute, Milan, Italy 6 Faculty of Philosophy, Vita-Salute San ...

Health tech company Inato developed an AI-powered patient prescreening tool to make it easier and faster for research sites to assess patient eligibility for clinical trial opportunities.